Get the Stockscreener App
60.70
0.71%
0.43
Pre-market:
60.15
-0.55
-0.91%
Tempus Ai Inc stock is traded at $60.70, with a volume of 4.65M.
It is up +0.71% in the last 24 hours and up +30.73% over the past month.
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
See More
Previous Close:
$60.27
Open:
$60.1
24h Volume:
4.65M
Relative Volume:
0.73
Market Cap:
$10.90B
Revenue:
$1.36B
Net Income/Loss:
$-302.91M
P/E Ratio:
-35.33
EPS:
-1.7182
Net Cash Flow:
$-219.93M
1W Performance:
+4.10%
1M Performance:
+30.73%
6M Performance:
-12.71%
1Y Performance:
-0.44%
1-Day Range:
$58.69
$61.97
1-Week Range:
$56.35
$63.11
52-Week Range:
$41.73
$104.32
Tempus Ai Inc Stock (TEM) Company Profile
Name
Tempus Ai Inc
Sector
Industry
Phone
800-976-5448
Address
600 WEST CHICAGO AVENUE, CHICAGO
Compare TEM vs VEEV, BTSG, HQY, HNGE
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TEM
Tempus Ai Inc
|
60.70 | 10.40B | 1.36B | -302.91M | -219.93M | -1.7182 |
VEEV
Veeva Systems Inc
|
192.01 | 28.83B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
70.56 | 13.69B | 13.65B | 169.86M | 412.12M | 1.0758 |
HQY
Healthequity Inc
|
96.57 | 7.55B | 1.34B | 230.70M | 440.96M | 2.6695 |
HNGE
Hinge Health Inc
|
88.52 | 6.42B | 646.34M | -512.40M | 202.76M | -6.6871 |
Tempus Ai Inc Stock (TEM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-13-26 | Initiated | Jefferies | Underperform |
| Apr-13-26 | Upgrade | TD Cowen | Hold → Buy |
| Feb-19-26 | Initiated | Mizuho | Outperform |
| Feb-17-26 | Initiated | Robert W. Baird | Outperform |
| Dec-02-25 | Resumed | Morgan Stanley | Overweight |
| Oct-21-25 | Downgrade | TD Cowen | Buy → Hold |
| Oct-20-25 | Initiated | Canaccord Genuity | Buy |
| Sep-02-25 | Initiated | H.C. Wainwright | Buy |
| Apr-21-25 | Initiated | BTIG Research | Buy |
| Feb-25-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-12-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Feb-05-25 | Resumed | TD Cowen | Buy |
| Dec-13-24 | Initiated | Wolfe Research | Outperform |
| Dec-09-24 | Initiated | Guggenheim | Buy |
| Nov-11-24 | Downgrade | Stifel | Buy → Hold |
| Oct-02-24 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-12-24 | Initiated | Piper Sandler | Neutral |
| Jul-09-24 | Initiated | BofA Securities | Buy |
| Jul-09-24 | Initiated | JP Morgan | Overweight |
| Jul-09-24 | Initiated | Longbow | Buy |
| Jul-09-24 | Initiated | Loop Capital | Buy |
| Jul-09-24 | Initiated | Morgan Stanley | Overweight |
| Jul-09-24 | Initiated | Needham | Buy |
| Jul-09-24 | Initiated | Stifel | Buy |
| Jul-09-24 | Initiated | TD Cowen | Buy |
| Jul-09-24 | Initiated | William Blair | Outperform |
View All
Tempus Ai Inc Stock (TEM) Latest News
Tempus AI (NASDAQ:TEM) Stock Rating Upgraded by Freedom Capital - MarketBeat
TEM Stock Slips Overnight: CEO-Linked $9.6M Share Sale Puts A Cloud Over 'AI As Physician' Story - Stocktwits
Tempus AI(TEM.US) 10% Shareholder Sells US$9.56 Million in Common Stock - Moomoo
CEO Eric Lefkofsky entities sell 166,250 Tempus AI (TEM) shares under 10b5-1 plan - Stock Titan
TEM Initiated Coverage by Freedom Capital Markets -- Rating Set to Hold - GuruFocus
Tempus AI (TEM) Holds Steady Near Support Amid Modest PullbackDollar Neutral Pair - dars.gov.et
Does Tempus AI’s (TEM) xH Launch Quietly Redraw Its Long‑Term Data Moat Strategy? - simplywall.st
Correction: Biovica Refocuses US Commercial Strategy and Terminates Agreement with Tempus AI - Yahoo Finance
Correction: Biovica refocuses US commercial strategy and terminates agreement with Tempus AI - TradingView
Biovica Refocuses US Commercial Strategy, Terminates Deal With Tempus AI - TradingView
Biovica refocuses US commercial strategy and terminates agreement with Tempus AI - marketscreener.com
Tempus AI: Buy On Diagnostics Momentum And AI Platform Expansion (NASDAQ:TEM) - Seeking Alpha
Form 4 Tempus AI Inc For: 29 June By Investing.com - Investing.com Canada
Tempus AI CFO James Rogers sells $634,095 in TEM stock - Investing.com UK
Tempus AI CFO James Rogers sells $634,095 in TEM stock By Investing.com - Investing.com Australia
Tempus AI director Jennifer Doudna sells $147,015 in stock By Investing.com - Investing.com Nigeria
Tempus AI (TEM) director sells 2,673 shares under 10b5-1 plan - Stock Titan
Form 144 Tempus AI For: 29 June By Investing.com - Investing.com South Africa
$Tempus AI (TEM.US)$ whats next …. - Moomoo
Tempus AI (NASDAQ: TEM) insiders report multi-holder Class A sales - Stock Titan
Tempus AI Stock Faces a Make-or-Break Moment After Its Recent Pullback - Barchart.com
Tempus AI, Inc. (TEM) Stock Analysis: Growth Prospects Amidst a Complex Financial Landscape - DirectorsTalk Interviews
Tempus AI (TEM) is Amongst AI stocks Under $30 That Carry High Short Interest - Insider Monkey
Tempus AI (TEM) Expands Rare Cancer Research, Is The Stock Fully Priced? - simplywall.st
5 Worst Artificial Intelligence Stocks Under $30 According to Short Sellers - Insider Monkey
How genetic testing company Tempus AI is using data and artificial intelligence to help personalize cancer care - MSN
Tempus AI Stock (TEM) Opinions on Healthcare AI Breakthroughs - Quiver Quantitative
Tempus AI Stock Short Interest Rises to 38.44% - Quiver Quantitative
Tempus AI, Inc. $TEM Shares Sold by SG Americas Securities LLC - MarketBeat
Tempus AI stock jumps on rare cancer research partnership - Investing.com
How Genetic Testing Company Tempus AI Is Using Data and Artificial Intelligence to Help Personalize Cancer Care - SurvivorNet
Why is Tempus AI stock rallying today? - Investing.com UK
TEM (NASDAQ: TEM) insider resale: 11,529 RSU shares listed for sale - Stock Titan
Why is Tempus AI stock rallying today? By Investing.com - Investing.com Nigeria
Investors Purchase High Volume of Call Options on Tempus AI (NASDAQ:TEM) - MarketBeat
Tempus AI, Inc. Class A Actuals & Estimates (NASDAQ:TEM) - TradingView
Tempus AI partners with Angiosarcoma Awareness on rare cancer research By Investing.com - Investing.com South Africa
Tempus AI stock jumps on rare cancer research partnership By Investing.com - Investing.com Nigeria
Tempus AI partners with Angiosarcoma Awareness on rare cancer research - Investing.com
Tempus Announces Research Collaboration with Angiosarcoma Awareness, Inc. to Uncover Insights on Rare Cancers - marketscreener.com
TEM Forecast — Price Target — Prediction for 2027 - TradingView
Enterprise value to EBITDA forward of Tempus AI, Inc. – NASDAQ:TEM - TradingView
Price to sales forward of Tempus AI, Inc. – NASDAQ:TEM - TradingView
Price to book forward of Tempus AI, Inc. – NASDAQ:TEM - TradingView
Enterprise value to EBIT forward of Tempus AI, Inc. – NASDAQ:TEM - TradingView
Enterprise value to revenue forward of Tempus AI, Inc. – NASDAQ:TEM - TradingView
Price to earnings forward of Tempus AI, Inc. – NASDAQ:TEM - TradingView
The pink kinda moving average line is a little problem, the red dashed is certainly a take profit and wait line - Moomoo
Is Tempus AI, Inc. (TEM) Among the Best AI Drug Discovery Stocks to Buy According to Hedge Funds? - Insider Monkey
Tempus Ai Inc Stock (TEM) Financials Data
Revenue
Net Income
Cash Flow
EPS
Tempus Ai Inc Stock (TEM) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Doudna Jennifer A | Director |
Jun 25 '26 |
Sale |
55.00 |
2,673 |
147,015 |
25,942 |
| Rogers James William | Chief Financial Officer |
Jun 25 '26 |
Sale |
55.00 |
11,529 |
634,095 |
114,866 |
1.32%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):